abstract |
The present disclosure relates to a binding agent, in particular an antibody, which binds to MICA and / or MICB; a composition comprising said binding agent; and said binding agent for the diagnosis and treatment of diseases characterized by elevated MICA and / or MICB protein About the use of. |